Clinical Trials

Title   AGCT1531 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Description   This partially randomized phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
IRB Number   18-006
Treatment   Pediatric Oncology - Germ Cell Tumor (GCT)
Status   active
Start Date   01/02/2018
Principal Name   Felicia Wilson, M.D.
Contact Name   Andretta McCovey

Email Newsletters

Connect With Us